Back

Fatal attraction: hypertension and atrial fibrillation - Current knowledge

28 August 2018 (16:45 - 17:03)
Organised by:
Congress Presentation Part of: Hypertension and Atrial Fibrillation Pathophysiology and Mechanisms ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Athanasios John Manolis

METROPOLIAN, Athens (Greece)

3 More presentations in this session

Presentation thumbnail
Long-term systolic blood pressure trajectories predict risk of incident atrial fibrillation in a general population cohort study
Doctor E. Sharashova (Tromso, NO)
Abstract Slides Video
Presentation thumbnail
Combination therapy with renin-angiotensin system inhibitors and statins is associated with reduced incidence of new-onset atrial fibrillation in hypertensive patients
Doctor T. Horio (Higashi-Osaka, JP)
Abstract
Presentation thumbnail
Efficacy and safety of edoxaban vs warfarin stratified by achieved blood pressure in 19,754 patients with hypertension in ENGAGE AF-TIMI 48
Professor S. Park (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertension and Atrial Fibrillation

The Event

Event poster

ESC Congress 2018

28 August 2018 16:45 CET
You may be interested in
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure
17 May 2025
thumbnail
Congress Presentation
Blood pressure levels and risk of haemorrhagic stroke in patients with atrial fibrillation and anticoagulants: results from a primary care cohort with hypertension
1 September 2020
thumbnail
Congress Presentation
Atrial fibrillation diagnosis by a systematic 14-day continuous ECG-Holter in patients with high cardiovascular risk and clinical palpitation: The prospective AFTER Study.
28 August 2022
thumbnail
Congress Presentation
Hypertension is an independent risk factor for diastolic dysfunction in atrial fibrillation without systolic dysfunction
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources